46 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Apr 22
Report of Foreign Private Issuer
8:15am
disease, (b) a more stringent regulatory environment, and (c) increased volatility of the potential business segment. Re-allocating cash resources … stringent regulatory environment, and (c) increased volatility of the potential business segment, Enlivex is de-prioritizing Allocetra’s clinical
20-F/A
2018 FY
ENLV
Enlivex Therapeutics Ltd
31 Jan 20
Annual report (foreign) (amended)
4:31pm
legal and finance personnel. Management is committed to maintaining a strong internal control environment and believes the above noted efforts … will represent significant improvements to the internal control environment.
(c) Attestation Report of the Registered Public Accounting Firm
This annual
6-K
EX-99.2
ENLV
Enlivex Therapeutics Ltd
27 May 22
Condensed Consolidated Financial Statements
4:39pm
because the U.S. dollar is the currency of the primary economic environment in which we operate and expect to continue to operate for the foreseeable … basis the amount of the lease payments in the same currency, for a similar term, in a similar economic environment.
Our leases include options to extend
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
22 Mar 21
Report of Foreign Private Issuer
8:02am
are excited about studying the effects of Allocetra™ in potentially recruiting anti-tumor macrophages in the tumor environment and characterize the effects
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
17 Aug 22
Current Report
8:02am
, stated, “With Allocetra™ treatment, we aim to change the balance of macrophage populations surrounding the solid tumor environment in favor of anti-cancer
6-K
EX-99.2
ssv7motagemqh ltgn
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.2
j7wz okkg2uk8
22 Aug 22
Condensed Consolidated Financial Statements
8:08am
6-K
EX-99.1
0dswayb
9 May 22
Report of Foreign Private Issuer
9:10am
6-K
EX-99.1
69h1g
16 Jun 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
gqkzg9fdel
27 May 22
Condensed Consolidated Financial Statements
4:39pm
6-K
EX-99.2
rco64dv
16 Jun 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
eigjg
9 Nov 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
hofnlqdap kovw
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.2
q8qf4bpss
1 Sep 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.2
pzig q2g0i1gswr
28 May 21
Condensed Consolidated Financial Statements
4:33pm
6-K
EX-99.2
lmjvp2
6 Aug 21
Condensed Consolidated Financial Statements
4:31pm
6-K
EX-99.2
n00ms80idc21s nlr3g
19 Nov 21
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.2
h10lkbl8vhvy
9 Nov 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
hvqzvij76jk3
1 Sep 23
Condensed Consolidated Financial Statements
4:30pm